tm logo
UPURA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 10 Oct 2016

Last Applicant/ Owned by

One Johnson & Johnson Plaza

New Brunswick

NJ

089337001

Serial Number

85495823 filed on 15th Dec 2011

Registration Number

N/A

Correspondent Address

Cheryl L. Foytlin

JEFFREY T BARAVETTO

191 N WACKER DRIVE SUITE 3700

CHICAGO, IL 60606-1698

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

UPURA

Human pharmaceuticals for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases, muscle dystonias, wrinkles and smooth muscle disorders

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceuticals for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases, muscle dystonias, wrinkles and smooth muscle disorders

Mark Details


Serial Number

No 85495823

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Oct 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
10th Oct 2016ABANDONMENT - NO USE STATEMENT FILED
26th Feb 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th Feb 2016EXTENSION 1 GRANTED
24th Feb 2016EXTENSION 1 FILED
24th Feb 2016TEAS EXTENSION RECEIVED
08th Sep 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30th Jul 2015OPPOSITION TERMINATED NO. 999999
30th Jul 2015OPPOSITION DISMISSED NO. 999999
30th Jul 2015TTAB RELEASE CASE TO TRADEMARKS